EVALUATION OF A NEW OESTROGEN RECEPTOR ASSAY

Publisher Website
Google Scholar
Abstract
Replicate assays of oestrogen receptor (ER) concentration on 81 specimens of human breast carcinoma were performed to compare the ligand binding Sephadex separation method with a polystyrene bead linked anti-oestrogen receptor monoclonal antibody technique (enzyme immunoassay [EIA], Abbott Laboratories). Each specimen was homogenized and the cytosol divided into four fractions. Replicate assays by each method gave an estimate of reproducibility. The mean CV (coefficient of variation = standard deviation/mean) for the ligand binding method was 9.73% compared with a mean CV of 17.9% for the EIA method. In the clinically significant range of ER values, around the cut-off point between negative and positive assays, there was no difference in the precision of the two assays (Mann Whitney U-test). The correlation between methods gave a Pearson''s Product Moment Correlation Coefficient (r value) of 0.822, significant at the P < 0.001 level, indicating a close correlation between the two methods. The highest CVs for both methods were in the range of oestrogen receptor concentrations, below 10 fmol/mg cytosol protein. Using 10 fmol/mg cytosol protein as a cut-off between negative and positive assays, 9.87% of the specimens would be reclassified as either positive or negative by the new assay method. The new assay method is therefore, acceptable for clinical use.